Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (42 quarters reported)
$988M in Q2 2013 → $19.9M now. Hover for any quarter.
As reported for the quarter ended September 30, 2023. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| BC Bain Cap Specialty Fin Inc | 67.6% | Added 1.5% | 878,701 | $13.5M |
| Celularity Inc. | 16.9% | Unchanged | 15,281,389 | $3.36M |
| AI American Intl Group Inc | 15.4% | Unchanged | 50,693 | $3.07M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended September 30, 2023 · filed November 14, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| BC Bain Cap Specialty Fin Inc | Added | +13,048 | +$200K | 67.6% |
quarter ended June 30, 2023 · filed August 14, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| AI American International Group Ord | Added | +35,000 | +$2.01M | 12.8% |
| BC Bain Capital Specialty Finance Ord | Added | +15,998 | +$216K | 51.5% |
quarter ended March 31, 2023 · filed May 03, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| AI American International Group Ord | Trimmed | −43,347 | −$2.18K | 3.9% |
| BC Bain Capital Specialty Finance Ord | Added | +12,687 | +$151 | 49.7% |
quarter ended December 31, 2022 · filed February 13, 2023
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| BC Bain Capital Specialty Finance Ord | Added | +12,465 | +$148 | 29.8% |
quarter ended September 30, 2022 · filed October 31, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| BC Bain Capital Specialty Finance Ord | Added | +10,692 | +$128K | 20.6% |
quarter ended June 30, 2022 · filed August 12, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| BC Bain Capital Specialty Finance Ord | Added | +9,912 | +$135K | 16.8% |
quarter ended March 31, 2022 · filed May 11, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Celularity Inc. | Added | +6,640,694 | +$57.8M | 89.1% |
| AI American International Group Ord | Trimmed | −3,748 | −$235K | 2.5% |
| BC Bain Capital Specialty Finance Ord | Added | +9,356 | +$146K | 8.4% |
quarter ended December 31, 2021 · filed January 27, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Celularity Inc. | New | +8,640,695 | +$44.2M | 73.9% |
| MO Moderna Ord | Exited | −67,000 | −$25.8M | — |
| AA Astrazeneca ADR Rep 0.5 Ord | Exited | −93,000 | −$5.59M | — |
| J& Johnson & Johnson Ord | Exited | −20,000 | −$3.23M | — |
Loading...
